Average Co-Inventor Count = 4.04
ph-index = 25
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Incyte Corporation (56 from 666 patents)
2. Incyte Holdings Corporation (13 from 147 patents)
3. Incyte Incorporation (1 from 4 patents)
4. Incyte Cororation (1 from 1 patent)
58 patents:
1. 12421197 - Aminopyrazine derivatives as PI3K-γ inhibitors
2. 12365668 - Aminopyrazine diol compounds as PI3K-y inhibitors
3. 12030885 - Substituted imidazo[2,1-f][1,2,4]triazines as PI3K-gamma inhibitors
4. 12006320 - Heterocyclic derivatives as PI3K inhibitors
5. 11958861 - Spirocyclic lactams as JAK2 V617F inhibitors
6. 11952367 - Pyridine and pyridimine compounds as PI3K-gamma inhibitors
7. 11926616 - Aminopyrazine diol compounds as PI3K-γ inhibitors
8. 11926630 - Tertiary alcohols as PI3K-γ inhibitors
9. 11773102 - Heterocyclic compounds as PI3K-γ inhibitors
10. 11744832 - Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
11. 11691971 - Naphthyridinone compounds as JAK2 V617F inhibitors
12. 11396502 - Substituted heterocyclic derivatives as PI3K inhibitors
13. 11352340 - Pyridine and pyridimine compounds as PI3K-gamma inhibitors
14. 11331320 - Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
15. 11306079 - 3-(5-amino-pyrazin-2-yl)-benzenesulfonamide derivatives and related compounds as PI3K-gamma kinase inhibitors